Pharmacoeconomics of Innovations or Innovation in Pharmacoeconomics: A “Relative Value” Analysis Instead of a “Cost-Effectiveness” Analysis?

Pharmacoeconomics: theory and practice
doi 10.30809/phe.2.2019.1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Moscow Pharmaceutical Society

Related search

Pharmacoeconomics of Bronchial Asthma

Folia Medica
Medicine
2019English

Pharmacoeconomics of Surfactant Therapy

Journal of Pediatric Pharmacology and Therapeutics
Child HealthPediatricsPerinatologyPharmacology
2006English

The Study of Pharmacoeconomics Analysis on Anti Tuberculosis Drugs Rifampicin & Ethambutol

International Journal of Research in Hospital and Clinical Pharmacy
2018English

Pcv88 - Pharmacoeconomics of Alirocumab in Treatment of Hypercholesterolemia: A Systematic Review

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pharmacoeconomics: State of the Art in 1997

Annual Review of Public Health
MedicineEnvironmentalPublic HealthOccupational Health
1997English

Understanding Health Outcomes and Pharmacoeconomics

2017English

Pmh4 - Pharmacoeconomics of Atypical Antipsychotics Induced Metabolic Syndrome: A Critical Evaluation of Cost Implications and Health Outcomes

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Value in Hepatitis C Virus Treatment: A Patient-Centered Cost-Effectiveness Analysis

PharmacoEconomics
Health PolicyPublic HealthOccupational HealthPharmacologyEnvironmental
2019English

Which Future for Pharmacoeconomics in Italy?

Farmeconomia. Health economics and therapeutic pathways
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy